Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 9/20 | 0.53 |
| ▸ | PPARG | P37231 | 13/20 | 0.51 |
| ▸ | PPARA | Q07869 | 5/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | RXRA | P19793 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10365768 | 0.92 | FFAR1 (0.54) | FFAR1PPARGPPARACYP3A4RXRA | |
| SCHEMBL4283015 | 0.87 | PPARG (0.63) | PPARGPPARACYP3A4 | |
| SCHEMBL170065 | 0.87 | PPARG (0.63) | PPARGPPARACYP3A4 | |
| SCHEMBL8461494 | 0.85 | FFAR1 (0.60) | FFAR1PPARGPPARA | |
| SCHEMBL7452156 | 0.84 | PPARG (0.49) | PPARGPPARACYP3A4 | |
| SCHEMBL6531845 | 0.81 | PPARG (0.61) | FFAR1PPARGPPARA | |
| SCHEMBL10367689 | 0.79 | PPARG (0.60) | PPARGPPARACYP3A4 | |
| SCHEMBL6960213 | 0.79 | PPARG (0.59) | PPARGPPARA | |
| SCHEMBL6968221 | 0.78 | PPARG (0.57) | FFAR1PPARGPPARARXRA | |
| SCHEMBL9827679 | 0.78 | PPARG (0.57) | FFAR1PPARGPPARACYP3A4RXRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2575455-A2 | METHODS AND COMPOSITIONS FOR TREATING A SUBJECT FOR CENTRAL NERVOUS SYSTEM (CNS) INJURY | The Regents of the University of California (US) | 2013-04-10 | — | — | EP | disclosed |
| WO-2011153377-A2 | METHODS AND COMPOSITIONS FOR TREATING A SUBJECT FOR CENTRAL NERVOUS SYSTEM (CNS) INJURY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-12-08 | — | — | WO | disclosed |
| EP-0804193-A4 | THIAZOLIDINE DERIVATIVES FOR THE TREATMENT OF PSORIASIS | KURTZ THEODORE W (US) | 2002-03-27 | — | — | EP | disclosed |
| US-6110951-A | LOWERING INSULIN DRUG THERAPY IN NON-OBESE, NON-DIABETIC INDIVIDUALS | BETHESDA PHARMACEUTICALS, INC. | 2000-08-29 | — | — | US | disclosed |
| EP-0804193-A1 | THIAZOLIDINE DERIVATIVES FOR THE TREATMENT OF PSORIASIS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1997-11-05 | — | — | EP | disclosed |
| US-5594015-A | Thiazolidine derivatives for the treatment of psoriasis | REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1997-01-14 | — | — | US | disclosed |
| WO-1995035108-A1 | THIAZOLIDINE DERIVATIVES FOR THE TREATMENT OF PSORIASIS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1995-12-28 | — | — | WO | disclosed |
| US-5053420-A | Antidiabetic agents | KURTZ, THEODORE W. | 1991-10-01 | — | — | US | disclosed |
| WO-1991005538-A2 | THIAZOLIDINE DERIVATIVES FOR THE TREATMENT OF HYPERTENSION | PERSHADSINGH HARRIHAR A (US) | 1991-05-02 | — | — | WO | disclosed |
| EP-0177353-B1 | THIAZOLIDINEDIONE DERIVATIVES, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 1990-04-11 | — | — | EP | disclosed |
| US-4725610-A | TREATMENT OF HYPERLIPEMIA AND DIABETES | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1988-02-16 | — | — | US | disclosed |
| EP-0177353-A2 | Thiazolidinedione derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1986-04-09 | — | — | EP | disclosed |